Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Tragara closes Series A financing to support oncology and inflammatory programs

March 16, 2007

Nektar advances PEG-irinotecan into phase I

March 16, 2007

Curis selects CUDC-101 from targeted cancer drug development platform

March 16, 2007

Adherex outlines achievements of 2006, updates goals for 2007

March 16, 2007

Recent patents cover new therapeutic agents for cancer

March 16, 2007

Astellas Pharma updates clinical progress of YM-155

March 16, 2007

SPA agreement for phase III EOquin trials in noninvasive bladder cancer

March 15, 2007

Virax grants Transgene access to Co-X-Gene technology

March 15, 2007

Cell Therapeutics seeks SPA for pixantrone trial in indolent NHL

March 15, 2007

Phase Ib/II data on single agent ADH-1 presented

March 15, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...